NCT06981026 The Effectiveness of Telemedicine Monitoring Prehabilitation in Prostate Cancer Patients Undergoing Radical Prostatectomy
| NCT ID | NCT06981026 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Olomouc |
| Condition | Prostatectomy |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2026-06-01 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2026-06-01 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study titled " The effectiveness of telemedicine monitoring prehabilitation in prostate cancer patients undergoing radical prostatectomy " investigates the impact of a structured telemedicine-supported prehabilitation and rehabilitation program on reducing postoperative urinary incontinence in patients with localized prostate cancer. Radical prostatectomy, a common treatment for localized prostate cancer, is often associated with complications such as urinary incontinence, which significantly affects quality of life. This study aims to address this issue by enhancing patients' physical conditioning and adherence to pre- and postoperative rehabilitation through the use of wearable devices and remote physiotherapy consultations.
Eligibility Criteria
Inclusion criteria: * Biopsy-confirmed localized prostate cancer (ICD code C.61). * Indicated for radical prostatectomy, with or without pelvic lymphadenectomy (ePLND). * Not previously treated for prostate cancer, including radiation therapy to the pelvis, major pelvic surgery, or placement of a penile implant or artificial urinary sphincter. * No known urethral stricture or colostomy or chronic urinary catheterization. * No medical or current psychiatric disorders that precludes their participation in the study. * Status of the musculoskeletal system allowing physical exercise. * Urinary continent at baseline. * Has reliable internet and the skills/knowledge to use technologies use for the study. Exclusion criteria: * Other malignant tumors, except for benign skin carcinoma. * Active treatment for other oncological diagnoses. * Presence of preoperative urinary incontinence. * Diagnosed mental or cognitive disorders. * Prior pelvic radiotherapy or hormone therapy for prostate cancer recurrence. * Severe musculoskeletal disorders preventing active exercise * Inability to use required technologies
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06981026 clinical trial?
This trial is open to male participants only, aged 40 Years or older, up to 80 Years, studying Prostatectomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06981026 currently recruiting?
Yes, NCT06981026 is actively recruiting participants. Contact the research team at Petra.Bastlova@fnol.cz for enrollment information.
Where is the NCT06981026 trial being conducted?
This trial is being conducted at Olomouc, Czechia.
Who is sponsoring the NCT06981026 clinical trial?
NCT06981026 is sponsored by University Hospital Olomouc. The trial plans to enroll 200 participants.